• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10607
Medical Device Problem Codes Failure to Advance (2524); Material Deformation (2976)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 10/30/2020
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the right coronary artery.A 3.00 x 38 synergy ii drug-eluting stent was advanced for treatment but failed to cross the lesion.The lesion was dilated again with a 3.0 x 20 balloon catheter.However, upon examination for re-insertion of the stent, the physician noticed that the stent struts were lifted.The procedure was completed with another of the same device.There were no patient complications nor injuries reported and no harm was done to the patient.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: synergy ii us mr 3.00 x 38mm stent delivery system was returned for analysis.A visual examination of the stent found mid and proximal stent damage with struts lifted.The undamaged stent outer diameter was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of tip damage.A visual and tactile examination of the hypotube found multiple kinks.A visual and tactile examination of the outer and inner lumen and mid-shaft section found no issues.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that stent damage occurred.The target lesion was located in the right coronary artery.A 3.00 x 38 synergy ii drug-eluting stent was advanced for treatment but failed to cross the lesion.The lesion was dilated again with a 3.0 x 20 balloon catheter.However, upon examination for re-insertion of the stent, the physician noticed that the stent struts were lifted.The procedure was completed with another of the same device.There were no patient complications nor injuries reported and no harm was done to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10905218
Report Number2134265-2020-16454
Device Sequence Number545586
Product Code NIQ
UDI-Device Identifier08714729840411
UDI-Public08714729840411
Combination Product (Y/N)N
Initial Reporter StateMD
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/18/2021
Device Model Number10607
Device Catalogue Number10607
Device Lot Number0024839229
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/17/2020
Initial Date Received by Manufacturer 11/09/2020
Supplement Date Received by Manufacturer01/12/2021
Initial Report FDA Received Date11/25/2020
Supplement Report FDA Received Date01/18/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-